Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
Biorxiv : the Preprint Server for Biology
|
May 13, 2026
A tumor metabolism-angiogenesis-immune axis governs immunotherapy responses
Inna Serganova, Giorgia Colombo, Francesco Ballesio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 2, 2022
Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors
Diwakar Davar, Roberta Zappasodi, Hong Wang, et al.
Nature Medicine
|
May 1, 2019
Rational design of anti-GITR-based combination immunotherapy
Roberta Zappasodi, Cynthia Sirard, Yanyun Li, et al.
Nature Communications
|
August 13, 2020
Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
Luis Felipe Campesato, Sadna Budhu, Jeremy Tchaicha, et al.
Nature Immunology
|
February 19, 2020
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
Haiping Wang, Fabien Franco, Yao-Chen Tsui, et al.
The Journal of Clinical Investigation
|
July 23, 2019
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
Danny N Khalil, Nathan Suek, Luis Felipe Campesato, et al.
Nature Immunology
|
November 17, 2025
Thrombospondin-1-CD47 signaling contributes to the development of T cell exhaustion in cancer
Chien-Huan Weng, Anais Assouvie, Lauren Dong, et al.
Cancer Cell
|
December 6, 2024
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
Yusuke Isshiki, Xi Chen, Matt Teater, et al.
The Journal of Experimental Medicine
|
May 23, 2022
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions
Sara E Schad, Andrew Chow, Levi Mangarin, et al.
Nature Communications
|
April 3, 2024
Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment
Jie Li, Christopher R Chin, Hsia-Yuan Ying, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
Biorxiv : the Preprint Server for Biology
|
May 13, 2026
A tumor metabolism-angiogenesis-immune axis governs immunotherapy responses
Inna Serganova, Giorgia Colombo, Francesco Ballesio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 2, 2022
Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors
Diwakar Davar, Roberta Zappasodi, Hong Wang, et al.
Nature Medicine
|
May 1, 2019
Rational design of anti-GITR-based combination immunotherapy
Roberta Zappasodi, Cynthia Sirard, Yanyun Li, et al.
Nature Communications
|
August 13, 2020
Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
Luis Felipe Campesato, Sadna Budhu, Jeremy Tchaicha, et al.
Nature Immunology
|
February 19, 2020
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
Haiping Wang, Fabien Franco, Yao-Chen Tsui, et al.
The Journal of Clinical Investigation
|
July 23, 2019
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
Danny N Khalil, Nathan Suek, Luis Felipe Campesato, et al.
Nature Immunology
|
November 17, 2025
Thrombospondin-1-CD47 signaling contributes to the development of T cell exhaustion in cancer
Chien-Huan Weng, Anais Assouvie, Lauren Dong, et al.
Cancer Cell
|
December 6, 2024
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
Yusuke Isshiki, Xi Chen, Matt Teater, et al.
The Journal of Experimental Medicine
|
May 23, 2022
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions
Sara E Schad, Andrew Chow, Levi Mangarin, et al.
Nature Communications
|
April 3, 2024
Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment
Jie Li, Christopher R Chin, Hsia-Yuan Ying, et al.
Page
of 7